Aspire Biopharma Holdings annual operating margin
2025
Aspire Biopharma Holdings Operating Margin Growth & History (ASBP)
Aspire Biopharma Holdings's operating margin was −312,016.95% for fiscal 2025.
View full Aspire Biopharma Holdings company overviewAspire Biopharma Holdings annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −312,016.95% | — |
Aspire Biopharma Holdings quarterly operating margin
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −4,244.14% | — |
| Q1 2026 | 2026-03-31 | −5,805.98% | — |
| Q4 2025 | 2025-12-31 | −43,403.52% | — |
| Q3 2025 | 2025-09-30 | −59,015.82% | — |
Aspire Biopharma Holdings operating margin trends
The latest reported quarter, Q2 2026, shows −4,244.14%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aspire Biopharma Holdings source filings ↗